Publications
See below the publications until 2019.
For the new once (2020 to ...) - please press the button below
88. Formation of trans-epoxy fatty acids correlates with formation of isoprostanes and could serve as biomarker of oxidative stress
Rund, K., Heylmann, D., Seiwert, N., Wecklein, S., Oger, C., Galano, J.-M., Durand, T., Chen, R., Gueler, F., Rund, K., Fahrer, J., Bornhorst, J., Schebb,N.
Prostaglandins and Other Lipid Mediators, 2019, 144, 106334-106344.
87. Lipid mediators from Timothy grass pollen contribute to the effector phase of allergy and prime dendritic cells for glycolipid presentation
González Roldán, N., Engel, R., Düpow, S., Jakob, K., Koops, F., Orinska, Z., Vigor, C., Oger, C., Galano, J.-M., Durand, T., Jappe, U., Duda, K. A.
Front. Immunol. 2019, 10, 974.
86. Identification and quantification of phytoprostanes and phytofurans of coffee and cocoa by and co-products
Ruesgas-Ramón, M., Figueroa-Espinoza M, C., Durand, E., Suarez-Quiroz, M . L., González-Ríos, O., Rocher, A., Reversat, G., Vercauteren, J., Oger, C., Galano, J.-M., Durand, T., Vigor, C.
Food & Function, 2019, 10, 6882-6891.
85. Increase in omega-6 and decrease in omega-3 polyunsaturated fatty acid oxidation elevates the risk of exudative AMD development in adults with Chinese diet
Leung, H. H., Ng, A. LK., Durand, T., Kawasaki, R., Oger, C., Balas, L., Galano, J.-M., Wong, I. YH.
Free Radic. Biol. Med. 2019, 145, 349-356.
84. New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds
Peña-Bautista, C., Vigor, C., Galano, J.-M., Oger, C., Durand, T., Ferrer, I., Cuevas, A., López-Cuevas, R., Baquero, M., López-Nogueroles, M., Vento, M., Hervás-Marín, D., García-Blanco, A., Cháfer-Pericás, C.
Scientific Reports, 2019, 9, 14244-14252.
83. Non-invasive assessment of oxidative stress in preterm infants
Peña-Bautista, C., Durand, T., Vigor, C., Oger, C., Galano, J.-M., Cháfer-Pericás, C.
Free Radic. Biol. Med. 2019, 142, 73-81.
82. Camelina sativa oil, fatty fish and lean fish do not markedly affect urinary prostanoids in subjects with impaired glucose metabolism
Erkkila, A., Lee, J. C.-Y., Lankinen, M., Manninen, S., Leung, H. H., Oger, C., Mello, V., Schwab, U.
Lipids, 2019, 54, 453-464.
81. Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis
Peña-Bautista, C., Durand, T., Oger, C., Baquero, M., Vento, M., Cháfer-Pericás, C.
Clinical Biochemistry, 2019, 72, 64-70.
80. Does Pasteurized Donor Human Milk Efficiently Protect Preterm Infants Against Oxidative Stress?
Parra-Llorca, A., Gormaz, M., Sánchez-Illana, A., Piñeiro-Ramos, J. D., Collado, M. C., Serna, E., Cernada, M., Nuñez-Ramiro, A., Ramón-Beltrán, A., Oger, C., Galano, J.-M., Vigor, C., Durand, T., Kuligowski, J., Vento M.
Antiox. Redox Signaling. News and Views, 2019, 31, 791-799.
79. The Value of Legume Foods as a Dietary Source of Phytoprostanes and Phytofurans Is Dependent on Species, Variety, and Growing Conditions
García-García, M. C., del Rio Celestino, M., Gil Izquierdo, A., Egea-Gilabert, C., Galano, J.-M., Durand, T., Oger, C., Fernández, J., Ferreres, F., Domínguez-Perles, R.
Eur. J. Lipid Sci. Technol. 2019, 1800484-1800496.
78. Phenolic, oxylipin and fatty acid profiles of the Chilean hazelnut (Gevuina avellana): Antioxidant activity and inhibition of pro-inflammatory and metabolic syndrome-associated enzymes
Pino Ramos, L. L.., Jiménez-Aspee, F., Theoduloz, C., Burgos-Edwards, A., Domínguez-Perles, R., Oger, C., Durand, T., Gil-Izquierdo, Á., Bustamante, L., Mardones, C., Marquez, K., Contreras, D., Schmeda-Hirschmann, G.
Food Chem. 2019, 298, 125026-125039.
77. Increased isoprostanoid levels in brain from murine model of Krabbe disease – relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity
Signorini, C., Cardile, V., Pannuzzo, G., Graziano, A. C. E., Durand, T., Galano, J.-M., Oger, C., Leoncini, S., Cortelazzo, A., Lee, J. C.-Y. Hayek, J., De Felice, C.
Free Radic. Biol. Med. 2019, 139, 46-54.
76. Garlic supplementation modified enzymatic omega-6 poyunsaturated fatty oxidation in mild hypercholesterolemia
Leung, H. H., Yau, Y. F., Lee, K. S., Lee, Y. Y., Oger, C., Durand, T., Galano, J.-M., Loke, W. M., Lee, J. C.-Y.
European Journal of Lipid Science & Technology, 2019, 121, 1900069-1900080.
75. Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers
Pena-Bautista, C., Carrascosa-Marco, P., Oger, C., Vigor, C., Galano, J.-M., Durand, T., Baquero, M., López-Nogueroles, M., Vento, M., Garcia-Blanco, A., Cháfer-Pericás, C.
J. Pharma. Biomed. Anal. 2019, 164, 742-749.
74. Comparative study of different cocoa (Theobroma cacao L.) clones in terms of their phytoprostanes and phytofurans contents
León-Perez, D., Medina, S., Londoño-Londoño, J., Cano-Lamadrid, M., Carbonell-Barrachina, A., Durand, T., Guy, A., Oger, C., Galano, J.-M., Ferreres, F., Jiménez-Cartagena, C., Restrepo-Osorno, J., Gil-Izquierdo, A.
Food Chem., 2019, 280, 231-239.
73. 1-Ethyl-3-methylimidazolium tartrate chiral ionic liquids: preparation, characterization and opportunities thereof
Castellan, T., Cuyamendous, C., Fitremann, J., Galano, J.-M., Oger, C., Guillen, F., Génisson, Y.
New. J. Chem. 2018, 42, 18739-18748.
72. Impact of salicylic acid content and growing environment on phytoprostane and phytofuran (stress biomarkers) in Oryza sativa L.
Pinciroli, M., Domínguez-Perles, R., Garbi, M., Abellán, A., Oger C., Durand, T., Galano, J.M., Ferreres, F., Gil-Izquierdo, A.
J. Agric. Food Chem. 2018, 66, 12561-12570.
71. Biological activities of Non-Enzymatic Oxygenated Metabolites of Polyunsaturated Fatty Acids (NEO-PUFAs) derived from EPA and DHA: New anti-arrhythmic compounds?
Galano, J.-M., Roy, J., Durand, T., Lee, J. C.-Y., Le Guennec, J.-Y., Oger, C., Demion, M. Mol. Aspects Med. 2018, 64, 161-168.
70. Non-Enzymatic Synthesis of Bioactive Isoprostanoids in the Diatom Phaeodactylumfollowing Oxidative Stress
Lupette, J., Jaussaud, A., Vigor, C., Oger, C., Galano, J.-M., Reversat, G., Vercauteren, J., Jouhet, J., Durand, T., Marechal, E.
Plant Physiol. 2018, 178, 1344-1357.
69. Dietary Oat Bran Increases Some Proinflammatory Polyunsaturated Fatty-Acid Oxidation Products and Reduces Anti-Inflammatory Products in Apolipoprotein E−/− Mice
Lee, J. C.-Y., AlGhawas, D. S., Poutanen, K., Leung, K. S., Oger, C., Galano, J.-M., Durand, T., El-Nezami, H.
Lipids, 2018, 53, 785-796.
68. Development of an LC-(ESI-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs
Rund, K. M., Ostermann, A. I., Kutzner, L., Galano, J.-M., Oger, C., Vigor, C., Wecklein, S., Seiwert, N., Durand, T. Schebb, N.H.
Anal. Chim. Acta, 2018, 1037, 63-74.
67. History of chemical routes towards cyclic non-enzymatic oxygenated metabolites of polyunsaturated fatty acids (Review)
Oger, C., Cuyamendous, C., de la Torre, A., Candy, M., Guy, A., Bultel-Poncé, V., Durand, T., Galano, J.-M.
Synthesis, 2018, 50, 3257-3280.
66. Cyclooxygenases and lipoxygenases are used by the fungus Podospora anserina to repel nematodes
Ferrari, R., Lacaze, I., Le Faouder, P., Bertrand-Michel, J., Oger, C., Galano, J.-M., Durand, T., Moularat, S., Chan Ho Tong, L., Boucher, C., Kilani, J., Petit, Y., Vanparis, O., Trannoy, C., Brun, S., Lalucque, H., Malagnac, F., Silar, P.
Biochim. Biophys. Acta - BBA - Gen. Subj. 2018, 1862, 2174-2182.
65. Isoprostanoids in clinical and experimental neurological disease models
Signorini, C., De Felice, C., Galano, J.-M., Oger, C., Leoncini, S., Cortelazzo, A., Ciccoli, L., Durand, T., Hayek, J., Lee, J. C. Y.
Antioxidants, 2018, 7, 88 (13 pages).
64. Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection
Peña-Bautista, C., Vigor, C., Galano, J.-M., Oger, C., Durand, T., Ferrer, I., Cuevas, A., Lopez-Cuevas, R., Baquero, M., Lopez-Nogueroles, M., Vento, M., Hervas, M., Garcia-Blanco, A., Chafer-Pericas, C. Free Radic. Biol. Med., 2018, 124, 388-394.
63. Isoprostanoids quantitative profiling of marine red and brown macroalgae
Vigor, C., Reversat, G., Rocher, A., Oger, C., Galano, J.-M., Vercauteren, J., Durand, T., Tonon, T., Leblanc, C., Potin, P.
Food Chem. 2018, 268, 452-462.
62. Effects of cyclic fatty acid monomers from heated vegetables oil on markers of inflammation and oxidative stress in male wistar rats
Mboma, J., Leblanc, N., Angers, P., Rocher, A., Vigor, C., Oger, C., Reversat, G., Vercauteren, J., Galano, J.-M., Durand, T., Jacques, H.
J. Agric. Food Chem. 2018, 66, 7172-7180.
61. Oxydized LDL triggers changes on oxidative stress and inflammation biomarkers in human macrophages
Lara-Guzmán, O. J., Gil-Izquierdo, A., Medina, S., Osorio, E., Álvarez-Quintero, R., Zuluaga, N., Oger, C., Galano, J.-M., Durand, T., Muñoz-Durango, K. Redox Biol. 2018, 15 (Supplement C), 1-11.
60. Reliable determination of new lipid peroxidation compounds as potential early Alzheimer Disease biomarkers
García-Blanco, A., Peña Bautista, C., Oger, C., Vigor, C., Galano, J.-M., Durand, T., Martín-Ibáñez, N., Baquero, M., Vento, M., Cháfer-Pericás, C.
Talanta, 2018, 184, 193-201.
59. Sorting out the phytoprostane and phytofuran profile in vegetable oils
Dominguez-Perles, R., Abellan, A., Leon, D., Ferreres, F., Guy, A., Oger, C., Galano, J.-M., Durand, T., Gil-Izquierdo, A.
Food Res. Int. 2018, 107, 619-628.
58. Aronia-citrus juice (polyphenol rich juice) intake and elite triathlon training: A lipidomic approach using representative oxylipins in urine
Garcia-Flores, L., Medina, S., Gómez, C., Wheelock, C., Cejuela, R., Martínez-Sanz, J. M., Oger, C., Galano, J.-M., Durand, T., Hernández Sáez, Á., Ferreres, F., Gil-Izquierdo, A.
Food Funct. 2018, 9, 463–475.
57. Relevance of 4-F(4t)-neuroprostane and 10-F(4t)-neuroprostane to neurological diseases
Signorini, C., De Felice, C., Durand, T., Galano, J.-M., Oger, C., Leoncini, S., Ciccoli, L., Carone, M., Ulivelli, M., Manna, C., Cortelazzo, A., Lee, J. C.-Y., Hayek, J.
Free Radic. Biol. Med. 2018, 115, 278-287.
56. Novel free-radical mediated lipid peroxidation biomarkers in newborn plasma
Sánchez-Illana, A., Thayyil, S., Montaldo, P., Jenkins, D., Quintás, G., Oger, C., Galano, J.-M., Vigor, C., Durand, T., Vento, M., Kuligowski, J.
Anal. Chim. Acta, 2017, 996, 88-97.
55. Effect of the dietary intake of melatonin- and hydroxytyrosol-rich wines by healthy female volunteers on the systemic lipidomic
related oxylipins
Marhuenda, J., Medina, S., Martinez-Hernández, P., Arina, S., Zafrilla, P., Mulero, J.,Oger, C., Galano, J.-M., Durand, T., Solana, A., Ferreres, F., López-García, J. J., Gil-Izquierdo, A.
Food & Function, 2017, 8, 3745-3757.
54. Comparative Study of the Phytoprostane and Phytofuran Content of Indica and Japonica Rice (Oryza sativa L.) Flours
Pinciroli, M., Domínguez-Perles, R., Abellan, A., Guy, A., Durand, T., Oger, C., Galano, J.-M., Ferreres, F., Gil-Izquierdo, A.
J. Agric. Food Chem., 2017, 65, 8938-8947.
53. Isoprostanes, Neuroprostanes, Phytoprostanes. An Overview of 25 Years of Research in Chemistry and Biology
Galano, J.-M., Lee, Y. Y., Oger, C., Vigor, C., Vercauteren, J., Durand, T., Giera, M., Lee, J. C.-Y.
Prog. Lipid Res, 2017, 68, 83-108.
52. Effects of In Utero PFOS Exposure on Transcriptome, Lipidome, and Function of Mouse Testi
Lai, K. P., Lee, J. C.-Y., Wan, H. T., Li, J. W., Wong, A.Y.-M., Chan, T.-F., Oger, C., Galano, J.-M., Durand, T., Leung, K. S., Leung, C. C.-T., Li, R., Wong, C.
Environ. Sci. Technol. 2017, 51, 8782−8794.
51. Total synthesis and in vivo quantitation of phytofurans derived from alpha -linolenic acid acid
Cuyamendous, C., Leung, K. S., Bultel-Poncé, V., Guy, A., Durand, T., Galano, J.-M.,* Lee, J. C.-Y.,* Oger, C.*
Eur. J. Org. Chem. 2017, 2486-2490.
50. Two sides of the same coin: NEO-PUFAs in Rett syndrome and post-infarction cardiac arrhythmias
Demion, M., Oger, C., Vigor, C., Thireau, J., Le Guennec, J.-Y., Durand, T., Galano, J.-M., Lee, J. C.-Y.,
Eur. J. Lipid Sci. Technol. 2017, 119, 1600320-1600327.
49. Short-time UVA exposure to human keratinocytes instigated polyunsaturated fatty acid without inducing lipid peroxidation
Leung, K. S., Chan, H. F., Leung, H. H., Galano, J.-M., Oger, C., Durand, T., Lee, J. C.-Y.
Free Radic. Res. 2017, 51, 269-280.
48. Melatonin and hydroxytyrosol protect against oxidative stress related to the central nervous system after the ingestion of three types of wine by healthy volunteers
Marhuenda, J., Medina, S., Martinez-Hernandez, P., Arina, S., Zafrilla, P., Mulero, J., Oger, C., Galano, J.-M., Durand, T., Ferreres, F., Gil-Izquierdo, A.
Food and Function, 2017, 8, 64-74.
47. Snapshot situation of oxidative degradation of the nervous system, kidney, and adrenal glands biomarkers - neuroprostane and dihomo-isoprostanes - urinary biomarkers from infancy to elderly adults
García-Flores, L.A., Medina, S., Martínez-Hernández, P., Oger, C., Galano, J.-M., Durand, T., Casas-Pina, T., Ferreres, F., Gil- Izquierdo, A.
Redox. Biol. 2017, 11, 586-591.
46. Potential applications of lipid peroxidation products - F4-neuroprostanes, F3-neuroprostanesn-6 DPA F2-dihomo-isoprostanes and F2-isoprostanes - In the evaluation of the allograft function in renal transplantation
De las Heras-Gómez, I., Medina, S., Casas-Pina, T., Marín-Soler, L., Tomás, A., Martínez-Hernández, P., Oger, C., Galano, J.-M., Durand, T., Jimeno, L., Llorente, S., Lozoya, E., Ferreres, F., Gil-Izquierdo, A.
Free Radic. Biol. Med. 2017, 104, 178-184.
45. DHA-derived oxylipins, neuroprostanes and protectins, differentially and dose-dependently modulate the inflammatory response in human macrophages: putative mechanisms through PPAR activation
Bosviel, R., Joumard-Cubizolles, L., Chinetti-Gbaguidi, G., Bayle, D., Copin, C., Hennuyer, N., Duplan, I., Staels, B., Zanoni, G., Porta, A., Balas, L., Galano, J.-M., Oger, C., Mazur, A., Durand, T., Gladine, C.
Free Radic. Biol. Med. 2017, 103, 146-154.
44. Non-enzymatic oxidized metabolite of DHA, 4(RS)-4-F4t-neuroprostane protects the heart against reperfusion injury
Roy, J., Fauconnier, J., Oger, C., Farah, C., Angebault-Prouteau, Thireau, J., C., Bideaux, P., Scheuermann, V., Bultel-Poncé, V., Demion, M., Galano, J.-M., Durand, T., Lee, J. C.-Y., Le Guennec, J.-Y.
Free Radic. Biol. Med. 2017, 102, 229-239.
43. Total synthesis of the isoketal 5-D2-IsoK natural product based on organocatalysis
Candy, M., Durand, T., Galano, J.-M.,* Oger, C.*
Eur. J. Org. Chem. 2016, 35, 5813-5816.
42. Thermal stress in melon plants: phytoprostanes and phytofurans as oxidative stress biomarkers and the effect of antioxidant supplementation
Yonny, M. E., Rodriguez Torrresi, A., Cuyamendous, C., Reversat, G., Oger, C., Galano, J.-M., Durand, T., Vigor, C., Nazareno, M. A.
J. Agric. Food Chem. 2016, 64, 8296-8304.
41. Assessment of isoprostanes in human plasma: technical considerations and the use of mass spectrometry
Lee, Y.Y., Galano, J.-M., Oger, C., Vigor, C., Reversat, G., Roy, J., Le Guennec, J.-Y., Durand, T., Lee, J. C.-Y.
Lipids, 2016, 51, 1217-1229.
40. The novelty of Phytofurans, Isofurans, Dihomo-Isofurans and Neurofurans: Discovery, Synthesis and Potential Application
Cuyamendous, C., de la Torre, A., Lee, Y. Y., Leung, K. S., Guy, A.., Bultel-Poncé, V., Galano, J.-M., Lee, J. C.-Y., Oger, C., Durand, T.
Biochimie, 2016, 130, 49-62
39. Extra virgin olive oil reduced polyunsaturated fatty acid and cholesterol oxidation in rodent liver: Is this accounted by hydroxytyrosol-fatty acid conjugation ?
Lee, Y. Y., Crauste, C., Wang, H., Leung, H. H., Vercauteren, J., Galano, J.-M., Oger, C., Durand, T., Wang, J. M.-F., J., Lee, J. C.-Y.
J. Chem. Res. Toxicol. 2016, 29, 1689-1698
38. Lipidomic approach in young adult triathletes: effect of supplementation with a polyphenols-rich juice on neuroprostane and F2-dihomo-isoprostane markers
Garcia-Flores, L. A., Medina, S., Oger, C., Galano, J.-M., Durand, T., Cejuela, R., Martinez-Sanz, J. M., Ferreres, F., Gil-Izquierdo, A.
Food and Function, 2016, 7, 4343-4355.
37. Benzoyl shift: a new approach to reverse regioselectivity in the monoprotection of vic-diols
de la Torre, A., Oger, C.,* Bultel-Poncé, V., Durand, T., Galano, J.-M.*
Synlett, 2016, 27, 2205-2208.
36. Antiepileptic drugs affect lipid oxidative markers - neuroprostanes and F2-dihomo-isoprostanes- in patients with epilepsy: differences among first-, second-, and third-generation drugs by UHPLC-QqQ-MS/MS
Medina, S., Carrasco-Torres, R., Amor, M. I., Oger, C., Galano, J.-M., Durand, T., Villegas-Martinez, I., Ferreres, F., Gil-Izquierdo, A.
RSC Adv. 2016, 6, 82969-82976.
35. Recent advances in the synthesis of tetrahydrofurans and applications in total synthesis
de la Torre, A., Cuyamendous, C., Bultel-Poncé, V., Durand, T., Galano, J.-M.,* Oger, C.* Tetrahedron, 2016, 72, 5003-5025.
34. Simultaneous quantitative profiling of 20 isoprostanoids from omega-3 and omega-6 polyunsaturated fatty acids by LC-MS/MS in various biological samples
Dupuy, A., Le Faouder, P., Vigor, C., Oger, C., Galano, J.-M., Dray, C., Lee, J. C.-Y., Valet, P., Gladine, C., Durand, T. Bertrand-Michel, J.
Anal. Chim. Acta, 2016, 921, 46-58.
33. Assessment of oxidative stress biomarkers - neuroprostanes and dihomo-isoprostanes - in the urine of elite triathletes after two weeks of moderate altitude training
Garcia-Flores, L. A., Medina, S., Cejuela, R., Martinez-Sanz, J. M., Oger, C., Galano, J.-M., Durand, T., Casas Pina, T., Martinez-Hernandez, P., Ferreres, F., Gil-Izquierdo, A.
Free Radic. Res. 2016, 50, 485-494
32. Non Enzymatic Metabolites of Polyunsaturated Fatty Acids: Friend of Foe
Bultel-Poncé, V., Durand, T., Guy, A., Oger, C., Galano, J.-M.
OCL - Oilseeds Fats Crops Lipids, 2016, 23, D118.
31. Non-enzymatic oxygenated metabolites of omega 3 polyunsaturated fatty acid: Bioactive drugs?
Roy, J., Le Guennec, J.-Y., Galano J.-M., Thireau, J., Bultel-Poncé, V., Demion, M., Oger, C., Lee, J. C.-Y., Durand, T.
Biochimie, 2016, 120, 56-61
30. Polymeric Nanocapsules prevent oxidation of core-loaded unsaturated fatty acids: envidence based on the effects of docosahexaenoic and neuroprostane acid on breast cancer cells
Roy, J., Teixeira Oliveira, L., Oger, C., Galano, J.-M., Bultel-Poncé, B., Richard, S., Grabe Guimaraes, A., Carneiro Vilela, J.-M., Spangler Andrade, M., Durand, T., Besson, P., Furtado Mosqueira, V. C., Le Guennec, J.-Y.
J. Exp. Clinic. Cancer Res. 2015, 34, 155-166.
29. Dependency of Phytoprostanes fingerprints of must and wine on viticulture and enological processes
Marhuenda, J., Medina, S., Diaz-Castro, A., Martinez-Hernandez, P., Arina, S., Zafrilla, P., Mulero, J., Oger, C., Galano, J.-M., Durand, T., Ferreres, F., Gil-Izquierdo, A.
J. Agric. Food Chem. 2015, 63, 9022-9028.
28. Synthesis and Discovery of Phytofuran: Metabolites of alpha-linolenic acid peroxidation
Cuyamendous, C., Leung, K. S., Durand, T., Lee, J. C.-Y., Oger, C., Galano, J.-M.
Chem. Commun. 2015, 51, 15696-15699
27. Facile synthesis of cyclopentenone B1 and L1-type Phytoprostanes
Guy, A., Flanagan, S., Durand, T., Oger, C., Galano, J.-M.
Front. Chem. 2015, 3, 1-10 (doi: 10.3389/fchem.2015.00041).
26. Profiling and relative quantification of multiply nitrated and oxidized fatty acids
Milic, I., Griesser, E., Vemula, V., Ieda, N., Nakagawa, H., Miyata, N., Galano, J.-M., Oger, C., Durand, T., Fedorova, M.
Anal. Bioanal. Chem. 2015, 407, 5587-5602.
25. Nonenzymatic lipid mediators, neuroprostanes, exert the antiarrhythmic properties of docosahexaenoic acid
Roy, J., Oger, C., Thireau, J., Roussel, J., Mercier-Touzet, O., Faure, D., Pinot, E., Farah, C., Taber, D. F., Cristol, J.-P., Lee, J. C.-Y., Lacampagne, A., Galano J.-M., Durand, T., Le Guennec, J.-Y.
Free Radic. Biol. Med. 2015, 86, 269-278
24. Prenatal exposure to the contaminant perfluorooctane sulfonate elevates lipid peroxidation during mouse fetal development but not the pregnant dam
Lee, Y. Y., Wong, C. K., C., Oger, C., Durand, T., Galano, J.-M., Lee, J. C.-Y
Free Radic. Res. 2015, 49, 1015-1025.
23. Hyperoxia elevates adrenic acid peroxidation in marine fish and is associated to reproductive pheromones mediators
Chung, M. L.S., Galano, J.-M., Oger, C., Durand, T., Lee, J. C.-Y.
Mar. Drugs, 2015, 13, 2215-2232.
22. Total syntheses and in vivo quantitation of novel neurofuran and dihomo-isofuran derived from docosahexaenoic acid and adrenic acid
de la Torre, A., Lee,Y. Y., Massoni, A., Guy, A., Bultel-Poncé, V., Durand, T., Oger, C., Lee, J. C.-Y., Galano, J.-M.
Chem. Eur. J. 2015, 21, 2442-2446.
Highlighted in Organic Portal
21. Dihomo-isoprostanes - nonenzymatic metabolites of AdA- are higher in epileptic patients compared to healthy individuals by new ultra high pressure liquid chromatography - triple quadrupole - tandem mass spectrometry method
Medina, S., de Miguel-Elizaga, I., Oger, C., Galano, J.-M., Durand, T., Martinez-Villanueva, M., Gil-Del Castillo, M. L., Villegas-Martinez I., Ferreres, F., Martinez-Hernandez, P., Gil-Izquierdo, A.
Free Radic. Biol. Med. 2015, 79, 154-163.
20. Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and alpha-linolenic acids: bioactivities and potential use as biomarkers
Galano, J.-M., Lee, J. C.-Y., Gladine, C., Comte, Blandine., Le Guennec, J.-Y, Oger, C., Durand, Thierry.
Biochim. Biophys. Acta BBA - Mol. Cell. Biol. Lipids, 2015, 1851, 446-455.
19. Role of the Non-enzymatic Metabolite of Eicosapentaenoic Acid, 5-epi-5-F3t-Isoprostane in the Regulation of [3H]d-Aspartate Release in Isolated Bovine Retina
Jamil, J., Bankhele, P., Salvi, A., Mannix, J. E., Oger, C., Guy, A., Galano, J.-M., Durand, T., Njie-Mbye, Y. F., Ohia, S. E., Opere, C. A.
Neurochem. Res. 2014, 39, 2360-2369.
18. Non enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids
Vigor, C., Bertrand-Michel, J., Pinot, E., Oger, C., Vercauteren, J., Le Faouder, P., Galano, J.-M., Lee, J.C.-Y., Durand, T.
J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 2014, 964, 65-78.
17. Nonenzymatic oxygenated metabolites of alpha-linolenic acid B1- and L1-phytoprostanes protect immature neurons from oxidant injury and promote differentiation of oligodendrocyte progenitors through PPAR-gamma activation
Minghetti, L., Salvi, R., Salvatori, M.-L., Ajmone-Cat, M.-A., De Nuccio, C., Visentin, S., Bultel-Poncé, V., Oger, C., Guy, A., Galano, J.-M., Greco, A., Bernardo, A., Durand, T.
Free Radic. Biol. Med. 2014, 73, 41-50
16. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome
De Felice, C., Della Ragione, F., Signorini, C., Leoncini, S., Pecorelli, A., Ciccoli, L., Scalabri, F., Marracino, F., Madonna, M., Belmonte, G., Ricceri, L., De Filippis, B., Laviola, G., Valacchi, G., Durand, T., Galano, J-M., Oger, C., Guy, A., Bultel-Poncé, V., Guy, J., Filosa, S., Hayek, Y., D'Esposito, M.
Neurobiol. Dis. 2014, 68, 66-77
15. Synthesis, Discovery and Quantitation of Dihomo-Isofurans: Biomarkers of In Vivo Adrenic Acid Peroxidation
de la Torre, A., Lee Y.Y., Oger, C., Sangild P.T., Durand, T., Lee J.C.-Y., Galano, J.-M.
Angew. Chem. Int. Ed. 2014, 53, 6249-6252.
Highlighted in Organic Portal
14. Oxygenated metabolites of n-3 polyunsaturated fatty acids as potential oxidative stress biomarkers: total synthesis of 8-F3t-IsoP, 10-F4t-NeuroP and [d4]-10-F4t-NeuroP
Guy, A., Oger, C., Heppekausen, J., Signorini, C., De Felice, C., Fürstner, A., Durand, T., Galano, J.-M.
Chem. Eur. J. 2014, 20, 6374-6380.
13. Effects of omega-3 polyunsaturated fatty acids on plasma proteome in Rett Syndrome
De Felice, C., Cortelazzo, A., Signorini, C., Guerranti, R., Leoncini, S., Pecorelli, A., Durand, T., Galano, J-M., Oger, C., Zollo, G., Montomoli, B., Landi, L., Bini, L., Valacchi, G., Ciccoli, L., Hayek, J.
Mediat. Inflamm. 2013, Article ID 723269, 9 pages
12. Fatty Acids and Autism Spectrum Disorders: The Rett Syndrome Conundrum
De Felice, C., Signiorini, C., Leoncini, S., Pecorelli, A., Durand, T., Galano, J.-M., Bultel-Poncé, V., Guy, A., Oger, C., Zollo, G., Valacchi, G., Ciccoli, L., Hayek, Y.
Food Nutr. Sci. 2013, 4, 71-75.
11. Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder
Signiorini, C., De Felice, C., Durand, T., Oger, C., Galano, J.-M., Leoncini, S., Pecorelli, A., Valacchi, G., Ciccoli, L., Hayek, Y.
Oxi. Med. Cell. Longev. 2013, Article ID 343824 (dx.doi.org/10.1155/2013/343824).
10. Isoprostanes and Neuroprostanes: Total synthesis, biological activityand biomarkers of oxidative stress in humans
Galano, J.-M., Mas, E., Barden, A., Mori, T., Signorini,C., De Felice, C., Barett, A., Opere, C., Pinot, E., Schewdehelm, E., Benndorf, R., Roy, J., Le Guennec, J.-Y., Oger, C., Durand,T.
Prostaglandins and Other Lipid Mediators 2013, 107, 95-102.
9. Are alkyne reductions chemo-, regio-, and stereoselective enough to provide pure (Z)-olefins in polyfunctionalized bioactive molecules?
Oger, C., Balas, L., Durand, T., Galano, J.-M.
Chem. Rev. 2013, 113, 1313-1350
8. F2-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome
Durand, T., De Felice, C., Signorini, S., Oger, C., Bultel-Poncé, V., Guy, A., Galano, J.-M., Leoncini, S.,Ciccoli, L., Pecorelli, A., Valacchi, G., Hayek, Y.
Biochimie 2013, 95, SI, 86-90.
7. Partial rescue of Rett Syndrome by omega-3 polyunsaturated fatty acids (PUFAs) oil
De Felice, C., Signorini, S., Durand, T., Ciccoli, L., Leoncini, S., D’Esposito, M., Filosa, S., Oger, C., Guy, A., Bultel-Poncé, V., Galano, J.-M., Pecorelli, A., De Felice, L., Valacchi, G., Hayek, Y.
Genes and Nutrition 2012, 7, 447-458.
6. Total synthesis of isoprostanes derived from adrenic acid and EPA
Oger, C., Bultel-Poncé, V., Guy, A., Durand, T., Galano, J.-M.
Eur. J. Org. Chem. 2012, 2621-2634.
5. F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome
De Felice, C., Signorini, S., Durand, T., Oger, C., Guy, A., Bultel-Poncé, V., Galano, J.-M., Ciccoli, L., Leoncini, S., D’Esposito, M., Filosa, S., Pecorelli, A., Valacchi, G., Hayek, Y.
J. Lipid Res. 2011, 52, 2287-2297.
4. The handy use of Brown's P2-Ni catalyst for a skipped diyne deuteration: application to the synthesis of a [d4]-labeled-F4t-neuroprostane
Oger, C., Bultel-Poncé, V., Guy, A., Balas, L., Rossi, J.-C., Durand, T., Galano, J.-M.
Chem. Eur. J. 2010, 16, 13976-13980.
3. Total Synthesis of 15-D2t- and 15-epi-15-E2t-Isoprostanes
Brinkmann, Y., Oger, C., Guy, A., Durand,T., Galano, J.-M.
J. Org. Chem. 2010, 75, 2411-2414
1. Stereocontrolled Access to Isoprostanes via a bicyclo[3.3.0]octene Framework
Oger, C., Brinkmann, Y., Bouazzaoui, S., Durand, T., Galano, J.-M.
Org. Lett. 2008, 10, 5087-5090.
2. Lipase-catalyzed regioselective monoacetylation of unsymmetrical 1,5-primary diols
Oger, C., Marton, S., Brinkmann, Y., Bultel-Poncé, V., Durand, T., Graber, M., Galano, J.-M.
J. Org. Chem. 2010, 75, 1892-1897.
ChemInform (DOI: 10.1002/chin.201027022).
Patents
4. Methods and Pharmaceutical compositions for the treatment of disorders or diseases associated with ryanodine receptor dysfunction
Lacampagne, A., Le Guennec, J.-Y., Bultel-Ponce, V., Galano, J.-M., Guy, A., Durand, T., Oger, C., Matecki, S., Dridi, H., Thireau, J., et al.
PCT Int. Appl. 2015, WO 2015197562 A1 20151230
3. Methods and Pharmaceutical compositions for the treatment of disorders or diseases associated with ryanodine receptor dysfunction
Lacampagne, A., Roy, J., Dridi, H., Matecki, S., Thireau, J., Le Guennec, J.-Y., Galano, J.-M., Oger, C., Bultel-Poncé, V., Guy, A., Durand, T.
European Patent 23 juin 2014, EP14305977.2
2. Methods and Pharmaceutical Composition for the Treatment and Prevention of Cardiac Arrhytmias
Le Guennec, J.-Y., Galano, J.-M., Oger, C., Thireau, J., Roy, J., Bultel-Poncé, V., Guy, A., Durand, T.
PCT Int. Appl. 2014, WO 2014086819 A1 20140612.
1. Methods and Pharmaceutical Composition for the Treatment and Prevention of Cardiac Arrhythmias
Le Guennec, J.-Y., Galano, J.-M., Oger, C., Thireau, J., Roy, J., Bultel-Poncé, V., Guy, A., Durand, T.
European Patent 5 December 2012 - EP12306519.3
Book Chapters
2. Comprehensive Guide to Autism, section 18: Biomarkers of lipid oxidative damage in Rett syndrome
De Felice, C., Signorini, C., Leoncini, S., Pecorelli, A., Durand, T., Galano, J-M., Oger, C., Bultel-Poncé, V., Valacchi, G., Ciccoli, L., Hayek, Y.
Springer V B Patel, V. Preedy, C. Martin (eds.) 2014; 2617-2632.
1. Chapter VI: Phytoprostanes, Isoprostanes and Neuroprostanes: The Lovely Story of n-3 and n-6 Polyunsaturated Fatty Acids Metabolites
in Polyunsaturated Fatty Acids: Sources, Antioxidant Properties and Health Benefits.
Galano, J-M., Oger, C., De la Torre, A., Cuyamendous, C., Bultel-Poncé, V., Guy, A., Reversat, G., Durand, T.
Nova Science Publishers, Inc. 2014, p 159-174